Physician

Andrew Orton, M.D.

According to 2025 Medicare claims, Andrew Orton, M.D. (NPI: 1053731356) practices radiation oncology in the Tucson, AZ market, with the plurality of this provider's patient population coming from Pima, AZ. This provider's primary affiliated billing organization is ARIZONA BLOOD AND CANCER SPECIALISTS, PLLC (NPI: 1093370918; TIN: 834425637) and primary practice location at 85716-1729. Orton is affiliated with the ABC Network (ACO ID: A5554), participating under the MSSP model.

Orton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 535 traditional Medicare patients, billed 25,026 HCPCS/CPT codes, and received $2,813,818 in Medicare payments. The top billing code was 78815 (Nuclear medicine study from skull base to mid-thigh with ct scan). Part D data shows 545 prescription claims across 162 beneficiaries totaling $156,027 in drug costs, led by Orgovyx (Relugolix). Open Payments data shows 52 records totaling $1,193. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $175,651 to $2,813,818. Similarly, Part D prescription costs have risen steadily, from $736 to $156,027. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.8M2018 Medicare payment: $175,651 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $903,090 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $453,134 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,505,964 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,691,488 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,092,672 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,813,818 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018341,629$175,651
201922511,256$903,090
20201918,852$453,134
202130915,937$1,505,964
202249627,750$1,691,488
202348525,185$2,092,672
202453525,026$2,813,818

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$78K$156K2015 Drug cost: $736 (USD; Tot_Drug_Cst)2016 Drug cost: $335 (USD; Tot_Drug_Cst)2017 Drug cost: $1,591 (USD; Tot_Drug_Cst)2018 Drug cost: $590 (USD; Tot_Drug_Cst)2019 Drug cost: $2,403 (USD; Tot_Drug_Cst)2020 Drug cost: $1,878 (USD; Tot_Drug_Cst)2021 Drug cost: $4,582 (USD; Tot_Drug_Cst)2022 Drug cost: $9,985 (USD; Tot_Drug_Cst)2023 Drug cost: $54,494 (USD; Tot_Drug_Cst)2024 Drug cost: $156,027 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151320$736
20161217$335
20172445$1,591
20181223$590
201962179$2,403
202045120$1,878
202178219$4,582
202276234$9,985
2023135439$54,494
2024162545$156,027

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
78815Nuclear medicine study from skull base to mid-thigh with ct scan146164$1,216
A9552Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries140155$280
77014Ct guidance for insertion of radiation therapy fields1261,161$91
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more134205$64
77300Calculation of radiation therapy dose123521$50

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OrgovyxRelugolix531,590$139,265
MyrbetriqMirabegron16480$8,543
Tamsulosin HclTamsulosin Hcl21113,484$2,690
GabapentinGabapentin34901$360
SilodosinSilodosin13420$317

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.52$1,193AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Andrew Orton, M.D.?

Tedicare shows public-source Medicare data for Andrew Orton, M.D. (NPI 1053731356), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Orton, M.D. have ACO affiliation data?

Andrew Orton, M.D. is shown with ACO affiliation data for ABC Network (MSSP, ACO ID A5554).

What billing organization is linked to Andrew Orton, M.D.?

Andrew Orton, M.D. is linked to ARIZONA BLOOD AND CANCER SPECIALISTS, PLLC (billing NPI 1093370918) in the available physician profile data.

Does Andrew Orton, M.D. have Open Payments data?

Andrew Orton, M.D. has 52 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.